Quickening the pace at which findings and innovations in life sciences can be brought onto the commercial market is the aim behind a new collaborative program headed by faculty of UC Berkeley’s Haas School of Business.
This process is known as translational medicine – the ‘translation’ of research findings into procedures and products.
Haas School of Business believes that life sciences and translational medicine have much to gain by learning from the entrepreneurial principles of the ‘Lean Startup’ – something that has changed approaches to new businesses the world over.
Lean Startup techniques ditch conventional business plans in favor of working more closely on areas such as agile development, which focuses on cross-functional teamwork and early delivery.
“Hold on to your hats because we’re all in for one heck of a ride in a wave of new science startups,” said Haas School of Business’ Andre Marquis, a member of the teaching team for the life sciences program which is hosted by the innovation branch (I-Corps) of biomedical research facility, the National Institutes of Health (NIH).
Get closer to your dream programme
Your consent preferences have been set.
Time to start exploring.
Your account has been removed.
You can still browse the site or sign up again once you have parental consent.
Get closer to your dream programme